Login / Signup

Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia.

Jing FangLyndsey C BolanosKwangmin ChoiXiaona LiuSusanne ChristieShailaja AkunuruRupali KumarDehua WangXiaoting ChenKenneth D GreisPeter StoilovMarie-Dominique FilippiJaroslaw P MaciejewskiGuillermo Garcia-ManeroMatthew T WeirauchNathan SalomonisHartmut GeigerYi ZhengDaniel T Starczynowski
Published in: Nature immunology (2016)
Toll-like receptor (TLR) activation contributes to premalignant hematologic conditions, such as myelodysplastic syndromes (MDS). TRAF6, a TLR effector with ubiquitin (Ub) ligase activity, is overexpressed in MDS hematopoietic stem/progenitor cells (HSPCs). We found that TRAF6 overexpression in mouse HSPC results in impaired hematopoiesis and bone marrow failure. Using a global Ub screen, we identified hnRNPA1, an RNA-binding protein and auxiliary splicing factor, as a substrate of TRAF6. TRAF6 ubiquitination of hnRNPA1 regulated alternative splicing of Arhgap1, which resulted in activation of the GTP-binding Rho family protein Cdc42 and accounted for hematopoietic defects in TRAF6-expressing HSPCs. These results implicate Ub signaling in coordinating RNA processing by TLR pathways during an immune response and in premalignant hematologic diseases, such as MDS.
Keyphrases